We regularly participate in life science events across the world and often invited to present to industry colleagues on trends, hot topics in the pharmacovigilance, clinical development and software development fields.

Formula for Case Intake Success

12 December 2017

Finding the perfect blend between people and machine to capture purer data, faster. Dr. Andrew Rut, of MyMedsandMe and April Davis of Accenture present their thoughts on case intake automation with a lens on process, AI, and data.

Capture Purer Data, Faster - Patients at the forefront of Reportum

15 September 2017

Latest Reportum drug safety keynote at World Drug Safety Congress in Berlin. Andrew Rut, shares insight and trends how to use digital innovation to establish an authentic reporter dialogue & transform process efficiency; Capturing relevant, essential and complete data at first interaction. Why surfacing targeted questions, FAQs in-stream maximises value of initial contact and reduces low value follow up. Digital solutions ensure your REMS and RMPS commitments are met with appropriate evidence.

Using risk-based approaches across the product lifecycle to simplify, standardise & enhance the collection of safety data

21 September 2016

Dr. Rut explores the product lifecycle and reviews the areas of pharmacovigilance focus and opportunities for improvement for each: • Clinical studies – Maximising intelligence based on limited data • New to market – Establishing safety profile • On Patent Product – License maintenance • Off Patent / OTC – Efficiency and automation

Addressing an Evolving Drug Safety Landscape - Moving from passive to active pharmacovigilance

20 April 2016

Pharma and Biotech organizations are facing growing challenges from the rapidly developing pharmacovigilance landscape and demands for the collection of more relevant safety data. These factors, combined with the pressure of cost containment, demand that life science organisations consider different approaches to the traditional, largely manual PV processes. A risk-based processing approach introduces a highly effective and efficient process to manage drug safety, ensuring quality data is collected across the portfolio, from newly launched to established products.

Addressing the Challenges of Safety Data Collection in Clinical Studies

13 April 2016

MyMeds&Me CEO Dr. Andrew Rut led a roundtable discussion at the Oracle Industry Connect event in Orlando. This discussion brought pharmacovigilance and clinical research experts together to discuss how to ensure that important safety data is captured at time of reporting and how processes can be dramatically improved through the use of technology solutions.

Pharmacovigilance, Drug Safety & Risk Management 2015 - Driving Risk Management through Intelligent Intake Technology

02 December 2015

MyMeds&Me CEO Dr. Andrew Rut presents the case for driving risk management through intelligent intake technology. Andrew outlines how pharmacovigilance professionals can move from passive to active PV fuelling better decision-making.

pvTech London Meeting - Managing an end-to-end Pharmacovigilance system

05 November 2015

MyMeds&Me CEO Dr. Andrew Rut explores how technology can help address the challenges facing Pharmacovigilance teams. He reviews how the latest intake technology can influence end-user experience and effectiveness, as well as internal value & efficiency.

Applying Technologies Across PV Processes to Increase Compliance and Quality

29 October 2015

MyMeds&Me CEO Andrew Rut and Oracle Health Science's Director of Safety Analytics, Michael Braun-Boghos review the positive impacts of technology on current pharmacovigilance processes.

Debating the Future of Spontaneous Reporting

20 April 2015

MyMeds&Me CEO Andrew Rut proposes the debate motion, “With the changes in society and increased use of electronic media, the role of the health professional in Yellow Card reporting will be diminished” at the MHRA Scientific Conference in Edinburgh - this year commemorating the 50th anniversary of the Yellow Card reporting scheme.

Keep informed

For expert insight and updates from the MyMeds&Me team.

We respect your privacy and we will only use your email address for newsletters and company updates